It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Staff shortages and delta threaten Japan's highly successful record of treating severe COVID-19 cases

National Aug 28, 2021

Staff shortages and delta threaten Japan's highly successful record of treating severe COVID-19 cases

by Osamu Tsukimori

As severe cases surge, hospitals have been hit by a lack of staff as well as a dearth of physicians capable of using special equipment such as ECMO machines.

Japan to use ¥1.4 trillion in reserve funds for COVID-19 measures

National Aug 27, 2021

Japan to use ¥1.4 trillion in reserve funds for COVID-19 measures

¥841.5 billion will be used for more vaccines, while around ¥235.2 billion was earmarked for coronavirus-related treatments.

Blood clot risk much higher for COVID-19 patients than from vaccines, study finds

World / Science & Health Aug 27, 2021

Blood clot risk much higher for COVID-19 patients than from vaccines, study finds

by Grace Gitau

The study followed 29 million people who received doses of either the AstraZeneca or Pfizer vaccine between December 2020 and April and about 1.7 million COVID-19 patients.

Japan turns to antibody cocktails as 'new weapon' in fight against pandemic

National | FOCUS Aug 24, 2021

Japan turns to antibody cocktails as 'new weapon' in fight against pandemic

by Tomohiro Osaki

The government has widened the use of the drug Ronapreve, but some doctors say it needs to go further and make it available to patients isolating at home too.

Australia's 'authoritarian' COVID-19 response

Commentary / World Aug 19, 2021

Australia's 'authoritarian' COVID-19 response

by Ramesh Thakur

Australia, once the envy of the world for its pandemic management, is now being criticized by some over the authoritarian measures it is using to crush COVID-19.

Hong Kong's COVID-19 policies are borderline reckless

Commentary / World Aug 19, 2021

Hong Kong's COVID-19 policies are borderline reckless

by Anjani Trivedi

The government’s inability to adapt while failing to put in place policies that ensure long-term safety are standing in the way of keeping the public's trust.

Antibody cocktails to treat COVID-19 take off as delta surges in U.S.

World | FOCUS Aug 17, 2021

Antibody cocktails to treat COVID-19 take off as delta surges in U.S.

As the delta variant surges, one drug cocktail is rapidly becoming a more common, even routine medical response to positive coronavirus tests in high-risk patients in the United States.

Can Moderna buy its way into the $200 billion club?

Commentary / World Aug 12, 2021

Can Moderna buy its way into the $200 billion club?

by Max Nisen

Moderna's COVID-19 windfall sees its market valuation surged by more than $100 billion since May.

Japan backs 'revolutionary' COVID-19 drug Ronapreve to help tame crisis

National Aug 11, 2021

Japan backs 'revolutionary' COVID-19 drug Ronapreve to help tame crisis

by Osamu Tsukimori

The antibody cocktail, intended for mildly and moderately ill patients, could in the near future be used to treat those quarantining at home, helping to ease the strain on hospitals.

Not vaccinated? Here’s how you could kill someone’s father

Commentary / World Aug 11, 2021

Not vaccinated? Here’s how you could kill someone’s father

by Faye Flam

Misinformation, or even mere scientific confusion, can cause a lot of trouble when it appears to come out of the Centers for Disease Control. That is what happened when a leaked CDC document helped send a misleading message that vaccinated people spread the new delta ...

China’s COVID-19 strategy risks leaving it isolated for years

Asia Pacific / Science & Health Aug 9, 2021

China’s COVID-19 strategy risks leaving it isolated for years

China is tethering itself to eliminating the virus over the long term — an approach that risks leaving the world’s second-biggest economy isolated for years to come.

Beyond delta, scientists are watching new coronavirus variants

World Aug 9, 2021

Beyond delta, scientists are watching new coronavirus variants

by Julie Steenhuysen

Scientists remain focused on delta, now the dominant variant rising rapidly around the world, but they are tracking others to see what may one day take its place.

« 1 … 26 27 28 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times